Prosecution Insights
Last updated: October 04, 2026

Emstop Inc.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Emstop Inc. has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are assigned to 2 distinct examiners and are both located within 1 distinct art unit. Bachman, Lindsey Michele is the busiest examiner for the portfolio, currently holding 1 pending office action. This requires the company to manage multiple examiner relationships within a single art unit environment.

The presence of 2 distinct examiners suggests that the company's technology is being evaluated by different individuals even within a single art unit. Practitioners should focus on the specific preferences of Bachman, Lindsey Michele, while also monitoring the progress of the other pending matter. Because the prosecution is limited to a single art unit, the company can tailor its strategy to the specific examination standards and historical trends of that unit. This focused approach may allow for more efficient resolution of the 2 pending office actions compared to portfolios spread across multiple units. Maintaining a unified argument across both cases is essential for success in the Medical Devices & Mechanical Engineering sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BACHMAN, LINDSEY MICHELE 1 48.5% +41.8%
RIVERS, LINDSEY RAE 1 64.1% +56.9%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17948933 Embolic Protection Catheter and Related Devices and Methods RIVERS, LINDSEY RAE 4d overdue
18862264 Embolic Filter Catheter BACHMAN, LINDSEY MICHELE 29d

Top Art Units

Art UnitApps
3771 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18862264 Embolic Filter Catheter BACHMAN, LINDSEY MICHELE 3771 §103 Final Rejection 29d Pending Nov 01, 2024
17948933 Embolic Protection Catheter and Related Devices and Methods RIVERS, LINDSEY RAE 3771 §103 Final Rejection 4d overdue Pending Sep 20, 2022

Managing Emstop Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month